Share-Based Compensation - Stock Options Activity (Details)
$ / shares in Units, shares in Thousands, $ in Thousands |
3 Months Ended |
|
May 01, 2021
USD ($)
$ / shares
shares
|
|---|
| Number of Shares |
|
| Outstanding at beginning of period (in shares) | shares |
3,324
|
| Granted (in shares) | shares |
0
|
| Exercised (in shares) | shares |
0
|
| Forfeited or expired (in shares) | shares |
(134)
|
| Outstanding at end of period (in shares) | shares |
3,190
|
| Expected to vest at end of period (in shares) | shares |
2,025
|
| Exercisable at end of period (in shares) | shares |
1,145
|
| Grant Date Weighted Average Exercise Price Per Share |
|
| Outstanding at beginning of period (in USD per share) | $ / shares |
$ 6.65
|
| Granted (in USD per share) | $ / shares |
0
|
| Exercised (in USD per share) | $ / shares |
0
|
| Forfeited or expired (in USD per share) | $ / shares |
18.60
|
| Outstanding at end of period (in USD per share) | $ / shares |
6.15
|
| Expected to vest at end of period (in USD per share) | $ / shares |
2.61
|
| Exercisable at end of period (in USD per share) | $ / shares |
$ 12.46
|
| Weighted-Average Remaining Contractual Life (in years) |
|
| Outstanding at end of period |
7 years
|
| Expected to vest at end of period |
8 years 2 months 12 days
|
| Exercisable at end of period |
4 years 10 months 24 days
|
| Aggregate Intrinsic Value |
|
| Outstanding at end of period | $ |
$ 1,044
|
| Expected to vest at end of period | $ |
909
|
| Exercisable at end of period | $ |
$ 126
|